tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

SLRN Stock Latest News

ACELYRIN, INC. Advances Key Drug Developments
Company AnnouncementsACELYRIN, INC. Advances Key Drug Developments
9d ago
SLRN
Acelyrin files $400M mixed securities shelf
PremiumThe Fly
Acelyrin files $400M mixed securities shelf
9d ago
SLRN
Acelyrin reports Q3 EPS (49c), consensus (80c)
PremiumThe Fly
Acelyrin reports Q3 EPS (49c), consensus (80c)
9d ago
SLRN
Is SLRN a Buy, Before Earnings?
PremiumPre-Earnings
Is SLRN a Buy, Before Earnings?
20d ago
SLRN
Acelyrin forms scientific, patient advisory board
PremiumThe Fly
Acelyrin forms scientific, patient advisory board
1M ago
SLRN
Acelyrin price target raised to $15 from $13 at Wells Fargo
PremiumThe FlyAcelyrin price target raised to $15 from $13 at Wells Fargo
1M ago
SLRN
Acelyrin announces positive results from Phase 3 trial of izokibep
Premium
The Fly
Acelyrin announces positive results from Phase 3 trial of izokibep
2M ago
SLRN
Acelyrin announces PoC data from Phase 1/2 trial of lonigutamab
Premium
The Fly
Acelyrin announces PoC data from Phase 1/2 trial of lonigutamab
2M ago
SLRN
Acelyrin price target lowered to $6 from $13 at Morgan Stanley
PremiumThe Fly
Acelyrin price target lowered to $6 from $13 at Morgan Stanley
3M ago
SLRN
Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz
PremiumThe Fly
Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz
3M ago
K
GM
Acelyrin price target lowered to $20 from $68 at Piper Sandler
PremiumThe Fly
Acelyrin price target lowered to $20 from $68 at Piper Sandler
3M ago
SLRN
Acelyrin downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Acelyrin downgraded to Neutral from Buy at H.C. Wainwright
3M ago
SLRN
ACELYRIN Refocuses on Thyroid Eye Disease, Cuts Workforce
PremiumCompany AnnouncementsACELYRIN Refocuses on Thyroid Eye Disease, Cuts Workforce
3M ago
8K
SLRN
Acelyrin reports Q2 EPS (86c), consensus (75c)
Premium
The Fly
Acelyrin reports Q2 EPS (86c), consensus (75c)
3M ago
SLRN
SLRN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SLRN Upcoming Earnings Report: What to Expect?
3M ago
SLRN
Wells upgrades Acelyrin to Overweight with shares trading below cash
PremiumThe Fly
Wells upgrades Acelyrin to Overweight with shares trading below cash
5M ago
SLRN
Acelyrin upgraded to Overweight from Equal Weight at Wells Fargo
PremiumThe Fly
Acelyrin upgraded to Overweight from Equal Weight at Wells Fargo
5M ago
SLRN
Acelyrin to present 16-week data from Phase 2b/3 trial of izokibep
PremiumThe Fly
Acelyrin to present 16-week data from Phase 2b/3 trial of izokibep
6M ago
SLRN
Acelyrin price target raised to $18 from $16 at H.C. Wainwright
PremiumThe Fly
Acelyrin price target raised to $18 from $16 at H.C. Wainwright
6M ago
SLRN
Acelyrin management to meet virtually with Piper Sandler
PremiumThe FlyAcelyrin management to meet virtually with Piper Sandler
6M ago
SLRN
Acelyrin management to meet virtually with Piper Sandler
Premium
The Fly
Acelyrin management to meet virtually with Piper Sandler
6M ago
SLRN
SLRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
SLRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7M ago
SLRN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >